ORLANDO, Fla., June 5 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. announced today the new branding campaign for its STATPATCH wireless heart monitor. “STATPATCH” represents the new brand name of the Company’s flagship wireless Holter monitor device. Telzuit continues to make significant advances in the development of mobile medical monitoring, and the new STATPATCH brand name signifies the breakthrough medical technology that accompanies Telzuit’s mission. Via the STATPATCH wireless Holter monitor, physicians will soon be able to monitor full 12-lead patient ECG data on a near real-time basis through Telzuit’s revolutionary mobile monitoring platform.
Warren Stowell, CEO of Telzuit, commented, “Our mission remains unchanged -- to provide wireless medical monitoring devices that revolutionize the way that physicians receive vital patient medical data. Our forthcoming STATPATCH heart monitor is the first step in this mission, and its new brand name represents the benefits of our wireless Holter monitor platform. Current Holter monitors utilize outdated technology that is cumbersome to the patient and inefficient to the physician on both a time- and cost-basis. Telzuit’s STATPATCH on the other hand utilizes wireless technology that allows for near real-time monitoring of ECG data that is both unobtrusive to the patient and cost-efficient for the physician.”
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The Company is in the final stages of launching its first product, the STATPATCH wireless heart monitor. The STATPATCH is a full 12-lead, completely wireless Holter monitor, which is new to the marketplace. In conjunction with its strategic partners, Telzuit is also building its own dedicated intranet platform to handle several of the products it will be releasing, including the STATPATCH. Telzuit is based in Orlando, Florida. For more information on Telzuit, its business model and its products, please visit the Company’s Web site: http://www.telzuit.com.
Contact: James Tolan Co-Founder, Telzuit Medical Technologies, Inc. 407-354-1222 Brainerd Communicators, Inc. Jennifer Gery (media) Todd St.Onge (investors) 212-986-6667
Telzuit Medical Technologies, Inc.
CONTACT: James Tolan, Co-Founder, Telzuit Medical Technologies, Inc.,+1-407-354-1222; Media: Jennifer Gery, Investors: Todd St.Onge, both ofBrainerd Communicators, Inc., +1-212-986-6667
Web site: http://www.telzuit.com/